BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1023 related articles for article (PubMed ID: 27686563)

  • 1. Neuroinflammatory component of gray matter pathology in multiple sclerosis.
    Herranz E; Giannì C; Louapre C; Treaba CA; Govindarajan ST; Ouellette R; Loggia ML; Sloane JA; Madigan N; Izquierdo-Garcia D; Ward N; Mangeat G; Granberg T; Klawiter EC; Catana C; Hooker JM; Taylor N; Ionete C; Kinkel RP; Mainero C
    Ann Neurol; 2016 Nov; 80(5):776-790. PubMed ID: 27686563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (11)C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areas.
    Park E; Gallezot JD; Delgadillo A; Liu S; Planeta B; Lin SF; O'Connor KC; Lim K; Lee JY; Chastre A; Chen MK; Seneca N; Leppert D; Huang Y; Carson RE; Pelletier D
    Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1081-92. PubMed ID: 25833352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis.
    Datta G; Colasanti A; Rabiner EA; Gunn RN; Malik O; Ciccarelli O; Nicholas R; Van Vlierberghe E; Van Hecke W; Searle G; Santos-Ribeiro A; Matthews PM
    Brain; 2017 Nov; 140(11):2927-2938. PubMed ID: 29053775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A longitudinal study of cortical grey matter lesion subtypes in relapse-onset multiple sclerosis.
    Sethi V; Yousry T; Muhlert N; Tozer DJ; Altmann D; Ron M; Wheeler-Kingshott C; Miller DH; Chard DT
    J Neurol Neurosurg Psychiatry; 2016 Jul; 87(7):750-3. PubMed ID: 26272028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortical and Subcortical Morphometric and Iron Changes in Relapsing-Remitting Multiple Sclerosis and Their Association with White Matter T2 Lesion Load : A 3-Tesla Magnetic Resonance Imaging Study.
    Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
    Clin Neuroradiol; 2019 Mar; 29(1):51-64. PubMed ID: 29299614
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Datta G; Colasanti A; Kalk N; Owen D; Scott G; Rabiner EA; Gunn RN; Lingford-Hughes A; Malik O; Ciccarelli O; Nicholas R; Nei L; Battaglini M; De Stefano N; Matthews PM
    J Nucl Med; 2017 Sep; 58(9):1477-1482. PubMed ID: 28302760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between white matter fiber damage and gray matter perfusion in large-scale functionally defined networks in multiple sclerosis.
    Ma AY; Vitorino RC; Hojjat SP; Mulholland AD; Zhang L; Lee L; Carroll TJ; Cantrell CG; Figley CR; Aviv RI
    Mult Scler; 2017 Dec; 23(14):1884-1892. PubMed ID: 28178867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortical Perfusion Alteration in Normal-Appearing Gray Matter Is Most Sensitive to Disease Progression in Relapsing-Remitting Multiple Sclerosis.
    Hojjat SP; Kincal M; Vitorino R; Cantrell CG; Feinstein A; Zhang L; Lee L; O'Connor P; Carroll TJ; Aviv RI
    AJNR Am J Neuroradiol; 2016 Aug; 37(8):1454-61. PubMed ID: 27012299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gray matter microglial activation in relapsing vs progressive MS: A [F-18]PBR06-PET study.
    Singhal T; O'Connor K; Dubey S; Pan H; Chu R; Hurwitz S; Cicero S; Tauhid S; Silbersweig D; Stern E; Kijewski M; DiCarli M; Weiner HL; Bakshi R
    Neurol Neuroimmunol Neuroinflamm; 2019 Sep; 6(5):e587. PubMed ID: 31355321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiles of cortical inflammation in multiple sclerosis by
    Herranz E; Louapre C; Treaba CA; Govindarajan ST; Ouellette R; Mangeat G; Loggia ML; Cohen-Adad J; Klawiter EC; Sloane JA; Mainero C
    Mult Scler; 2020 Oct; 26(12):1497-1509. PubMed ID: 31368404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DT MRI microstructural cortical lesion damage does not explain cognitive impairment in MS.
    Preziosa P; Pagani E; Morelli ME; Copetti M; Martinelli V; Pirro F; Falini A; Comi G; Filippi M; Rocca MA
    Mult Scler; 2017 Dec; 23(14):1918-1928. PubMed ID: 28098510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of global and regional gray matter volume decrease in multiple sclerosis.
    Grothe M; Lotze M; Langner S; Dressel A
    J Neurol; 2016 Jun; 263(6):1137-45. PubMed ID: 27094570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into disseminated MS brain pathology with multimodal diffusion tensor and PET imaging.
    Bezukladova S; Tuisku J; Matilainen M; Vuorimaa A; Nylund M; Smith S; Sucksdorff M; Mohammadian M; Saunavaara V; Laaksonen S; Rokka J; Rinne JO; Rissanen E; Airas L
    Neurol Neuroimmunol Neuroinflamm; 2020 May; 7(3):. PubMed ID: 32123046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal change in TSPO PET imaging in progressive multiple sclerosis.
    Kang Y; Pandya S; Zinger N; Michaelson N; Gauthier SA
    Ann Clin Transl Neurol; 2021 Aug; 8(8):1755-1759. PubMed ID: 34310086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of diffuse cerebellar neuroinflammation in multiple sclerosis by
    Barletta VT; Herranz E; Treaba CA; Ouellette R; Mehndiratta A; Loggia ML; Klawiter EC; Ionete C; Jacob SA; Mainero C
    Mult Scler; 2020 May; 26(6):668-678. PubMed ID: 30973800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic counterparts of sodium accumulation in multiple sclerosis: A whole brain
    Donadieu M; Le Fur Y; Maarouf A; Gherib S; Ridley B; Pini L; Rapacchi S; Confort-Gouny S; Guye M; Schad LR; Maudsley AA; Pelletier J; Audoin B; Zaaraoui W; Ranjeva JP
    Mult Scler; 2019 Jan; 25(1):39-47. PubMed ID: 29064346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vivo Detection of Diffuse Inflammation in Secondary Progressive Multiple Sclerosis Using PET Imaging and the Radioligand ¹¹C-PK11195.
    Rissanen E; Tuisku J; Rokka J; Paavilainen T; Parkkola R; Rinne JO; Airas L
    J Nucl Med; 2014 Jun; 55(6):939-44. PubMed ID: 24711650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TSPO PET with [
    Unterrainer M; Mahler C; Vomacka L; Lindner S; Havla J; Brendel M; Böning G; Ertl-Wagner B; Kümpfel T; Milenkovic VM; Rupprecht R; Kerschensteiner M; Bartenstein P; Albert NL
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1423-1431. PubMed ID: 29523925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiparameter MRI quantification of microstructural tissue alterations in multiple sclerosis.
    Lommers E; Simon J; Reuter G; Delrue G; Dive D; Degueldre C; Balteau E; Phillips C; Maquet P
    Neuroimage Clin; 2019; 23():101879. PubMed ID: 31176293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep gray matter changes in relapsing-remitting multiple sclerosis detected by multi-parametric, high-resolution magnetic resonance imaging (MRI).
    Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
    Eur Radiol; 2021 Feb; 31(2):706-715. PubMed ID: 32851443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.